IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.
BörsenkürzelIRMD
Name des UnternehmensIRadimed Corp
IPO-datumJul 16, 2014
CEOMr. Roger Susi
Anzahl der mitarbeiter160
WertpapierartOrdinary Share
GeschäftsjahresendeJul 16
Addresse1025 Willa Springs Dr.
StadtWINTER SPRINGS
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl32708
Telefon14076778022
Websitehttps://www.iradimed.com/
BörsenkürzelIRMD
IPO-datumJul 16, 2014
CEOMr. Roger Susi
In den vergangenen 5 Jahren wurden insgesamt
39.46M
USD an Dividenden ausgeschüttet.
IRMD.NB Interim Cash Dividend of gross USD 0.17 paid on Mar 05, 2025 going ex on Feb 24, 2025
IRMD.NB Final Cash Dividend of gross USD 0.15 paid on Nov 25, 2024 going ex on Nov 15, 2024
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on Aug 30, 2024 going ex on Aug 20, 2024
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on May 30, 2024 going ex on May 17, 2024
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on Jan 12, 2024 going ex on Dec 21, 2023